Zurich Cantonal Bank’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,685
Closed -$96.8K 2682
2024
Q3
$96.8K Hold
16,685
﹤0.01% 2431
2024
Q2
$111K Buy
16,685
+6,227
+60% +$50.3K ﹤0.01% 2334
2024
Q1
$136K Sell
10,458
-4,066
-28% -$54.2K ﹤0.01% 2253
2023
Q4
$185K Buy
14,524
+6,363
+78% +$64.3K ﹤0.01% 2127
2023
Q3
$107K Buy
8,161
+1,376
+20% +$25.2K ﹤0.01% 2323
2023
Q2
$174K Buy
6,785
+1,983
+41% +$51.2K ﹤0.01% 2018
2023
Q1
$121K Hold
4,802
﹤0.01% 2183
2022
Q4
$110K Buy
+4,802
New +$111K ﹤0.01% 2207

Other funds holding TMCI

Zurich Cantonal Bank's TMCI Position: Q4 2024 in Review

Zurich Cantonal Bank sold out of Treace Medical Concepts (TMCI) in Q4 2024, closing a stake of 16,685 shares — an estimated $96.8K sold.

Zurich Cantonal Bank first reported a position in TMCI in Q4 2022 and held it in 8 quarters. The position peaked at $185K in Q4 2023. 135 funds tracked by Wall St. Rank hold TMCI as of Q4 2024.

  • Zurich Cantonal Bank reported no remaining Treace Medical Concepts position as of Q4 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 16,685 Treace Medical Concepts shares in Q4 2024, an estimated $96.8K.
  • Zurich Cantonal Bank first reported a position in Treace Medical Concepts in Q4 2022 and held it in 8 quarters.
  • Zurich Cantonal Bank's Treace Medical Concepts position peaked at $185K in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2024.

Based on Zurich Cantonal Bank's 13F filing for Q4 2024, filed 7 Feb 2025.